Acne Vulgaris
📧 Sign up to get email alerts when something new happens for Acne Vulgaris.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-10-28FDA Approved: DOXYCYCLINE — Original Application (Meitheal Pharmaceuticals Inc.)
The FDA approved Meitheal Pharmaceuticals' generic doxycycline as an Original Application (ANDA 218053), enabling market entry of a doxycycl…
-
CLINICAL_TRIALS research · 2024-10-23Clinical Trial Update: Intense Pulsed Light (IPL) Medical Device as Treatment for Patient Suffering From Skin Disorder [NA]
An intense pulsed light (IPL) device is being studied for multiple skin conditions, including hirsutism, vascular lesions, pigmented skin le…
-
FDA approval · 2024-10-11FDA Approved: TRETINOIN — Supplemental Application (Endo USA, Inc.)
FDA approved a supplemental application for TRETINOIN submitted by Endo USA, Inc., resulting in a change to the labeling or indication of th…
-
CLINICAL_TRIALS trial_result · 2024-10-10Clinical Trial Update: Patient-reported Outcomes for Sarecycline Effectiveness and Safety (PROSES)
This clinical trial update reports patient-reported outcomes on the effectiveness and safety of Sarecycline (Seysara) for acne vulgaris from…
-
CLINICAL_TRIALS withdrawal · 2024-10-09Clinical Trial Update: An Investigation of a Multi-Function Skincare Product to Improve Aging, Eczema, and Acne Outcomes [NA]
A clinical trial evaluating a multi-function skincare product for acne and eczema (with considerations for skin aging) has been withdrawn; s…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: Evaluation of Efficacy and Tolerance of Crystal Peel in the Treatment of Adults Presenting Facial Mild Acne [NA]
Completed clinical trial evaluating the efficacy and tolerance of Crystal Peel for facial mild acne in adults; results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-09-26Clinical Trial Update: Study Comparing Trifarotene Cream, 0.005% To AKLIEF ® (Trifarotene 0.005% Cream) In The Treatment Of Acne Vulgaris [Phase 3]
A Phase 3 trial comparing Teva's Trifarotene Cream 0.005% with AKLIEF (trifarotene 0.005% cream) for acne vulgaris has completed and results…
-
CLINICAL_TRIALS trial_result · 2024-09-20Clinical Trial Update: The Impact of Probiotics on Skin Hydration in Youth with Mild Acne [Phase 2]
Phase 2 trial evaluating a probiotic formulation for improving skin hydration in youths with mild acne has been completed, sponsored by Lall…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Fractional CO2 Laser Delivery of Topical Insulin Versus Platelet Rich Plasma in Treatment of Atrophic Post Acne Scars [NA]
Clinical trial evaluating fractional CO2 laser delivery of topical insulin versus platelet-rich plasma for the treatment of atrophic post-ac…
-
CLINICAL_TRIALS trial_result · 2024-08-30Clinical Trial Update: Autologous Plasma Gel Injection Versus Polydioxanone Cog Threads Insertion for the Treatment of Atrophic Post-acne Scars: a Split-face [NA]
A clinical trial comparing autologous plasma gel injections with polydioxanone cog thread insertions for treating atrophic post-acne scars i…
-
CLINICAL_TRIALS research · 2024-08-29Clinical Trial Update: Vitamin D Supplementation in Acne [NA]
A clinical trial is evaluating vitamin D supplementation for acne vulgaris and is currently recruiting participants.
-
FDA approval · 2024-08-26FDA Approved: ADAPALENE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for adapalene submitted by Actavis Pharma, Inc.
-
CLINICAL_TRIALS trial_result · 2024-08-23Clinical Trial Update: A Clinical Trial to Evaluate the Effectiveness of an Acne Serum in Improving Facial Acne and Post-Acne Pigmentation [NA]
Update on a completed clinical trial evaluating the effectiveness of an acne serum for facial acne and post-acne pigmentation.
-
CLINICAL_TRIALS trial_result · 2024-08-23Clinical Trial Update: Evaluating Microneedling With CBD and Hempseed Oil for Acne Vulgaris Safety and Efficacy [Phase 1]
Phase 1 clinical trial evaluating microneedling with cannabidiol (CBD) and hempseed oil for safety and efficacy in acne vulgaris; the study …
-
FDA approval · 2024-08-20FDA Approved: CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE — Original Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved Padagis Israel Pharmaceuticals Ltd's clindamycin phosphate and benzoyl peroxide topical product under an Original Application (…
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: A Study to Assess the Safety and Efficacy of a Sunscreen on Acne-Prone Skin With Inflammatory and Non-Inflammatory Acne Vulgaris [NA]
A completed clinical trial assessed the safety and efficacy of a sunscreen on acne-prone skin with inflammatory and non-inflammatory acne vu…
-
CLINICAL_TRIALS research · 2024-08-09Clinical Trial Update: Evaluation of the Efficacy and Safety of Microneedling Combined With Botulinum Toxin-A Versus Meso-Botox Injection in the Treatment of Atrophic Acne Scars: A Split-face Comparative Study [NA]
Clinical trial evaluating microneedling combined with Botulinum toxin A versus meso-Botox injections for treating atrophic acne scars; the s…
-
FDA approval · 2024-07-15FDA Approved: TAZAROTENE — Original Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved Padagis Israel Pharmaceuticals Ltd's Original Application for Tazarotene, establishing a generic topical retinoid. The product …
-
CLINICAL_TRIALS research · 2024-07-15Clinical Trial Update: Profiles Analysis of Genome Wide Association Study (GWAS) in Acne Vulgaris in Indonesia. [NA]
A GWAS-based study profile in Indonesia aims to identify genetic factors associated with acne vulgaris; the trial is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-07-11Clinical Trial Update: Impact of Tripolar Radiofrequency on Acne Scar [NA]
The study evaluating tripolar radiofrequency treatment for acne scars has completed; the excerpt provides status but no efficacy results.
-
FDA approval · 2024-06-28FDA Approved: ABSORICA — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for ABSORICA (isotretinoin) from Sun Pharmaceutical Industries, resulting in labeling changes for th…
-
FDA approval · 2024-06-26FDA Approved: ISOTRETINOIN — Supplemental Application (Amneal Pharmaceuticals NY LLC)
The FDA approved a supplemental application for isotretinoin from Amneal Pharmaceuticals NY LLC.
-
FDA approval · 2024-06-17FDA Approved: ADAPALENE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for adapalene submitted by Sun Pharmaceutical Industries, Inc.
-
CLINICAL_TRIALS trial_result · 2024-06-11Clinical Trial Update: Study of Trifarotene Cream to Assess Risk of a Trophic Acne Scar Formation [Phase 4]
Phase 4 trial update evaluating trifarotene cream for safety in acne vulgaris, specifically assessing the risk of trophic acne scar formatio…
-
CLINICAL_TRIALS trial_result · 2024-06-11Clinical Trial Update: Acne Remission Maintenance by Weekend Systemic Isotretinoin [Phase 3]
This clinical trial update notes the completion of a Phase 3 study evaluating weekend systemic isotretinoin for acne vulgaris.